肝细胞癌的管理：孟加拉国视角
Management of Hepatocellular Carcinoma: Bangladesh Perspective.
作者信息
Noor-E-Alam Sheikh M
机构信息
Department of Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.
出版信息
Euroasian J Hepatogastroenterol. 2018 Jan-Jun;8(1):52-53. doi: 10.5005/jp-journals-10018-1258. Epub 2018 May 1.
Bangladesh is one of the countries facing huge burden of hepatocellular carcinoma (HCC). Hepatocellular carcinoma is the third commonest cancer in the country and it is just behind to cancer of the lung and cancer of the stomach. Hepatitis B virus (HBV) is responsible for 66% of HCC in Bangladesh. Presumptive prevalence of HBV and hepatitis C virus (HCV) may be as high as 5.4 and 0.84%, respectively, in Bangladesh, and liver diseases occupied 8 to 12% of admission in medicine wards of Public Medical College. In this mini review, I would like to highlight the impact of HBV and HCV in the development of HCC and the management of HCC from a Bangladesh perspective. Noor-E-Alam SM. Management of Hepatocellular Carcinoma: Bangladesh Perspective. Euroasian J Hepato-Gastroenterol 2018;8(1):52-53.
孟加拉国是面临肝细胞癌（HCC）巨大负担的国家之一。肝细胞癌是该国第三大常见癌症，仅次于肺癌和胃癌。在孟加拉国，66%的肝细胞癌由乙型肝炎病毒（HBV）引起。孟加拉国HBV和丙型肝炎病毒（HCV）的推定患病率可能分别高达5.4%和0.84%，在公立医学院的内科病房中，肝病患者占入院人数的8%至12%。在这篇小型综述中，我想从孟加拉国的角度强调HBV和HCV对HCC发展的影响以及HCC的管理。努尔 - 伊 - 阿拉姆·SM。肝细胞癌的管理：孟加拉国视角。《欧亚肝脏胃肠病学杂志》2018年；8(1):52 - 53。
Zotero 插件